Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Identification of factors associated with a high success rate of treatment-free remission in chronic myeloid leukemia: A multicenter study in Taiwan

Ning-Chun Chen, Ming-Chung Kuo, Tung-Huei Lin, Ming-Chun Ma, Ching-Yuan Kuo, Hung Chang, Hsuan-Jen Shih, Tung-Liang Lin, Hsiao-Wen Kao, Chang-Liang Lai, Tsai-Yun Chen, Chih-Cheng Chen, Ming-Chung Wang, Lee-Yung Shih

Blood (2025) 146 (Supplement 1): 3781.

https://doi.org/10.1182/blood-2025-3781

Published: 2025

Journal Articles

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Ying-Jung Huang, Ming-Chung Kuo, Tung-Liang Lin, Ming-Chun Ma, Chieh-Lin Jerry Teng, Young-Sen Yang, Tsai-Yun Chen, Chiu-Chen Chen, Cheng-Shyong Chang, Hung Chang, Ting-Yu Huang, Tung-Huei Lin, Yen-Min Huang, Su-Peng Yeh, Ming-Chung Wang, Lee-Yung Shih

Blood (2025) 146 (Supplement 1): 5555.

https://doi.org/10.1182/blood-2025-5555

Published: 2025

Journal Articles

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

Sung-Nan Pei, MD, Kuan-Chih Huang, Ming-Chung Wang, MD, Ching-Yuan Kuo, Ming-Chun Ma, MD, Chun-Kai Liao, MD, Lee Anne Rothwell, PhD, Hong Qiu, MD PhD, Yanfang Liu, MD MPH

Blood (2018) 132 (Supplement 1): 5338.

https://doi.org/10.1182/blood-2018-99-112347

Published: 2018

Journal Articles

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Yi-Jiun Su, MD, Ming-Chung Kuo, MD, Chieh-Lin Teng, MD, Tsai-Yun Chen, MD, Ming-Chun Ma, MD, Pei-Ching Hsiao, MD, Ming-Chung Wang, MD, Tung-Huei Lin, MS, Wen-Li Hwang, MD, Chih-Cheng Chen, MD, Youngsen Yang, MD, Sung-Nan Pei, MD, Yen-Min Huang, MD, Sin-Syue Li, MD, Ming-Yang Lee, MD, Hung-I Cheng, MD, Lee-Yung Shih, MD

Blood (2017) 130 (Supplement 1): 1603.

https://doi.org/10.1182/blood.V130.Suppl_1.1603.1603

Published: 2017

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Identification of factors associated with a high success rate of treatment-free remission in chronic myeloid leukemia: A multicenter study in Taiwan

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Identification of factors associated with a high success rate of treatment-free remission in chronic myeloid leukemia: A multicenter study in Taiwan

Genetic evolution in CML patients from diagnosis to TKI failure: An analysis of 121 paired diagnosis and treatment failure samples

Risk Factors Associated with Earlier Relapse and Death and Treatment Response in Patients with Follicular Lymphoma in Taiwan

Comparison of Molecular Responses between e14a2 and e13a2 BCR-ABL1 Transcripts in Patients with Chronic Myeloid Leukemia in Chronic Phase Treated with Front-Line Second Generation Tyrosine Kinase Inhibitors: Taiwan CML Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only